• Home
  • NEW DAY MEDICINE
  • 3 (35) 2021
  • 49 -3 (35) 2021 — Badritdinova M., Nurilloeva Sh.N. — THE PREVALENCE OF METABOLIC SYNDROME AND ITS MAJOR COMPONENTS IN VARIOUS CATEGORIES OF HYPERGLYCEMIA

49 -3 (35) 2021 — Badritdinova M., Nurilloeva Sh.N. — THE PREVALENCE OF METABOLIC SYNDROME AND ITS MAJOR COMPONENTS IN VARIOUS CATEGORIES OF HYPERGLYCEMIA

THE PREVALENCE OF METABOLIC SYNDROME AND ITS MAJOR COMPONENTS IN VARIOUS CATEGORIES OF HYPERGLYCEMIA

Badritdinova M., Bukhoro State Medical Institute

Nurilloeva Sh.N. Bukhoro State Medical Institute

Resume

The prevalence of obesity and overweight in various categories of hyperglycemia was studied. Data on the prevalence of disorders of the sympathoadrenal phase of the glycemic curve were obtained. It was found that all categories of hyperglycemia, including the violation of the sympathoadrenal phase of the glycemic curve, are associated with obesity and overweight.

Keywords: hyperglycemia, hyperlipidemia, metabolic syndrome (МS).

First page

256

Last page

259

For citation: Badritdinova M., Nurilloeva Sh.N. THE PREVALENCE OF METABOLIC SYNDROME AND ITS MAJOR COMPONENTS IN VARIOUS CATEGORIES OF HYPERGLYCEMIA //New Day in Medicine 3(35)2021 256-259 https://cutt.ly/9ExHlWp

List of References:

  1. Ng M. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 // The Lancet. 2014. Vol. 384. №. 9945. P. 766–781.
  2. Муромцева Г. А. и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012–2013 гг. Результаты исследования ЭССЕ-РФ // Кардиоваскулярная терапия и профилактика. 2014. Т. 13. № 6. С. 4–11.
  3. World Health Organization Media Centre. Obesity and overweight. Fact sheet no Geneva: World Health Organization; 2013.
  4. James WPT, Jackson-Leach R, Mhurdu CN, Kalamara E, Shayeghi M, Rigby N, Nishida C, Rodgers A. Overweight and Obesity. In Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors: eds. Ezzati M, Lopez AD, Rodgers A, Murray CJL. WHO, Geneva, 2003. Ligibel JA et al. American Society of Clinical Oncology position statement on obesity and cancer // Journal of Clinical Oncology. 2014. Vol. 32. № 31. P. 3568–3574.
  5. Mahmood TA, Arulkumaran S. Obesity: A ticking time bomb for reproductive health. Newnes, 2012. Jungheim ES et al. Obesity and reproductive function //Obstetrics and gynecology clinics of North America. 2012. Vol. 39. № 4. P. 479–493.
  6. Jiao L et al. Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts // Cancer Causes & Control. 2010. Vol. 21. № 8. P. 1305–1314.
  7. NurilloevaSh.N., JuraevaKh.I. Adequacy pharmacotherapy of metabolic syndrome.// World journal of pharmaceutical research. August-Sept. – 2020.Volume 9. Issue 12.– P. 48-53.

file

download